Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (10) , 153113
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 32 references indexed in Scilit:
- Predictors of Gastrin Elevation Following Proton Pump Inhibitor TherapyJournal of Clinical Gastroenterology, 2020
- Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK ActivationCellular and Molecular Gastroenterology and Hepatology, 2020
- Sporadic Duodenal Bulb Gastrin-cell Tumors: Association With Helicobacter pylori Gastritis and Long-term Use of Proton Pump InhibitorsAmerican Journal of Surgical Pathology, 2006
- Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosaEuropean Journal of Gastroenterology & Hepatology, 2005
- Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatmentHuman Pathology, 2000
- Review article: current perspectives on hypergastrinaemia and enterochromaffin‐like‐cell hyperplasiaAlimentary Pharmacology & Therapeutics, 1999
- Parietal cell protrusions in gastric ulcer diseaseHuman Pathology, 1997
- Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasiaGastroenterology, 1997
- Classification and Grading of GastritisAmerican Journal of Surgical Pathology, 1996
- Time-dependent changes in enterochromaffinlike cell kinetics in stomach of hypergastrinemic ratsGastroenterology, 1993